A CRISPR first: editing normal human embryos.


In the first ever report of the CRISPR-Cas9 genome-editing tool being used on normal human embryos, a team of Chinese scientists had mixed results, New Scientist writes. The team first created embryos with genetic mutations that caused two different diseases: β-thalassemia and favism (an anemia caused by eating fava beans). When they tried correcting the mutations using CRISPR-Cas9, their success rate was one in four for β-thalassemia and two in two for favism, they report this month in Molecular Genetics and Genomics. That’s better than the 10% success rate for genetically abnormal embryos, but far more work needs to be done before the technique is ready for prime time, say other scientists.

CRISPR debate fueled by publication of second human embryo–editing paper

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s